- Title
- Continuous subcutaneous Insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study
- Creators
- Philip Raskin - University of Texas, Southwestern Medical Center, Dallas, Texas, United StatesBruce W Bode - Atlanta Diabetes Associates, Atlanta, Georgia, United StatesJennifer B Marks - University of Miami, Miami, Florida, United StatesIrl B Hirsch - University of Washington, Seattle, Washington, United StatesRichard L Weinstein - Diablo Clinical Research, Walnut Creek, Californnia, United StatesJanet B Mcgill - Washington University, St. Louis, Missouri, United StatesGregory E Peterson - Diagnostic and Critical Care Medicine, Des Moines, Iowa, United StatesSunder R Mudaliar - VA Medical Center, San Diego, California, United StatesRickey R Reinhardt - Novo Nordisk Pharmaceuticals, Princeton, New Jersey, United States
- Publication Details
- Diabetes care, Vol.26(9), pp.2598-2603
- Publisher
- American Diabetes Association
- Language
- English
- Resource Type
- Journal article
- PMID
- 12941725
- Record Identifier
- 991031615102602976
Journal article
Continuous subcutaneous Insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study
Diabetes care, Vol.26(9), pp.2598-2603
2003
PMID: 12941725
Metrics
5 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.26 Diabetes
- 1.26.42 Diabetes
- Web Of Science research areas
- Endocrinology & Metabolism
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites